Back
Protagonist Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
44
PTGX
Protagonist Therapeutics
Last Price:
47.62
Seasonality Move:
18.58%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.09 | Sell |
| 20-day SMA: | 46.37 | Sell |
| 50-day SMA: | 45.14 | Buy |
| 200-day SMA: | 34.63 | Buy |
| 8-day EMA: | 46.69 | Sell |
| 20-day EMA: | 46.38 | Sell |
| 50-day EMA: | 44.64 | Buy |
| 200-day EMA: | 35.99 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 48.74 | Sell |
| Chaikin Money Flow: | 154951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.55 - 47.39) | Sell |
| Bollinger Bands (100): | (35.98 - 45.9) | Buy |
Protagonist Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 45.90 while PTGX 8-day simple moving average is 47.09, which is a Sell signal.
- The stock price of PTGX is 45.90 while Protagonist Therapeutics 20-day SMA is 46.37, which makes it a Sell.
- Protagonist Therapeutics 50-day simple moving average is 45.14 while PTGX share price is 45.90, making it a Buy technically.
- PTGX stock price is 45.90 and Protagonist Therapeutics 200-day simple moving average is 34.63, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
44
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a Sell
The current Protagonist Therapeutics [PTGX] share price is $45.90. The Score for PTGX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.7B
Price in USD:
45.90
Share Volume:
848.54K
Protagonist Therapeutics 52-Week Range
52-Week High:
48.89
52-Week Low:
14.78
Sell
44
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?
The Protagonist Therapeutics stock price is 45.90 USD today. -
Will PTGX stock go up or go down?
Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protagonist Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 45.90 while PTGX 8-day exponential moving average is 46.69, which is a Sell signal.
- The stock price of PTGX is 45.90 while Protagonist Therapeutics 20-day EMA is 46.38, which makes it a Sell.
- Protagonist Therapeutics 50-day exponential moving average is 44.64 while PTGX share price is 45.90, making it a Buy technically.
- PTGX stock price is 45.90 and Protagonist Therapeutics 200-day simple moving average is 35.99, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.98 per share, and a decrease next year of $3.62 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
- PTGX Moving Average Covergence Divergence (MACD) indicator is 0.55, suggesting Protagonist Therapeutics is a Buy
- Protagonist Therapeutics Relative Strength Index (RSI) is 48.74, which suggest Protagonist Therapeutics is oversold
- The Bollinger Bands (25) for Protagonist Therapeutics is (44.55 - 47.39), which suggest Protagonist Therapeutics is a Buy
- The Bollinger Bands (100) for Protagonist Therapeutics is (35.98 - 45.9), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.